1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monoclonal antibody therapy of cancer
    Journal Article

    Jurcic, J. G.; Scheinberg, D. A.; Houghton, A. N.
    Cancer Chemotherapy and Biological Response Modifiers (1993)

    Fulltext@MSK | Save
  • Monoclonal antibodies in the treatment of myelogenous leukemias
    Journal Article

    Scheinberg, D. A.
    Cancer Treatment and Research (1993)

    Fulltext@MSK | Save
  • Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β
    Journal Article

    Mathias, S.; Younes, A.; Kan, C. C.; Orlow, I.; Joseph, C.; Kolesnick, R. N.
    Science (1993)

    Fulltext@MSK | Save
  • Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody
    Journal Article

    Co, M. S.; Scheinberg, D. A.; Avdalovic, N. M.; McGraw, K.; Vasquez, M.; Caron, P. C.; Queen, C.
    Molecular Immunology (1993)

    Fulltext@MSK | Save
  • Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers
    Journal Article

    Ballon, D.; Mahmood, U.; Jakubowski, A.; Koutcher, J. A.
    Magnetic Resonance in Medicine (1993)

    Fulltext@MSK | Save
  • Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML)
    Conference Paper

    Clarkson, B.; Strife, A.; Perez, A.; Lambek, C.; Wisniewski, D.
    Taylor & Francis Group (1993)

    Fulltext@MSK | Save
  • Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand
    Journal Article

    Strife, A.; Perez, A.; Lambek, C.; Wisniewski, D.; Bruno, S.; Darzynkiewicz, Z.; Clarkson, B.
    Leukemia Research (1993)

    Fulltext@MSK | Save
  • Interleukin-1: Biological effects in human hematopoiesis
    Journal Article

    Crown, J.; Jakubowski, A.; Gabrilove, J.
    Leukemia and Lymphoma (1993)

    Fulltext@MSK | Save
  • Cytokinetic considerations relevant to development of a successful therapeutic strategy in chronic myelogenous leukemia (CML)
    Conference Paper

    Clarkson, B.; Strife, A.
    Taylor & Francis Group (1993)

    Fulltext@MSK | Save
  • Anti-CD33 monoclonal antibody m195 for the therapy of myeloid leukemia
    Conference Paper

    Caron, P. C.; Scheinberg, D. A.
    Taylor & Francis Group (1993)

    Fulltext@MSK | Save